Giorgia Guglielmi

Giorgia Guglielmi is a freelance science writer based in Basel, Switzerland. Specializing in life sciences, medicine, and the relationship between science and society, she has published numerous articles in outlets including Nature, Science, and Scientific American. She holds a PhD in biology from the European Molecular Biology Laboratory and a Master’s in Science Writing from the Massachusetts Institute of Technology. She has received recognition for her work, including the John Kendrew Award in 2020 and an ERC-funded FRONTIERS Media Fellowship in 2025. She has also led lectures and workshops on science communication at institutions such as Harvard University and the University of Zurich.

Study reveals the trajectory of phages in the infant gut ecosystem

The findings of a recent study suggest that different factors, including maternal seeding and phage persistence in the gut, contribute to the colonization of the gut by phages.

Gut microbes influence cognitive performance in baby mice

The findings of a recent study show that specific gut microbes and their metabolites affect cognition and memory when transplanted into germ-free mice.

The cloudy link between gut microbes and obesity

Although a causative relationship between obesity and gut microbes remains unclear, microbiota-based treatments may help to combat obesity.

Study characterizes the microbiota of milk from mothers with preterm infants

The findings of a recent study shed light on the microbiota of the main nutrition types that preterm infants receive and may inform future studies on the influence of different…

How gut bacteria can help relieve constipation

A recent study indicates that the abfA cluster might be used as therapeutic target for constipation in humans.

In Crohn’s disease model, a fiber-free diet inhibits colitis by regulating gut bacteria

The findings of a recent study may inform new approaches to treat Crohn’s disease by targeting disease-causing microbes in the gut.

Gut fungi may be linked to inflammation in severe COVID

The findings of a recent study suggest that mycobiota changes during a SARS-CoV-2 infection could contribute to inflammation associated with severe COVID.

‘Hidden’ bacteria could explain recurrent urinary tract infections

The findings of a recent study indicate that effective treatments for recurrent UTIs may require the ability to penetrate human tissues.

Immune responses to gut microbes may indicate who benefits from diabetes therapy

The findings of a recent study indicate that antibodies to gut microbes could help identify who may benefit from teplizumab.

Some gut microbes are linked to negative clinical outcomes in people with HIV

The findings of a recent study suggest that the conversion of dietary fiber or lactate to SCFAs influences comorbidity risk associated with HIV.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top